Search research articles
Contact Us
Filters
Showing results (701-710 of 754) with videos related to
Page
of 76
Sort By:
Clinical Trials (London, England)
|
April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challenges
Thomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal
|
May 3, 2005
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease
T-Christian H Mix, Robert M Brenner, Mark E Cooper, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 28, 2020
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices
Matthew A Sparks, Andrew M South, Andrew D Badley, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
Journal of the American Heart Association
|
November 19, 2021
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF
Leanne Mooney, Nathaniel M Hawkins, Pardeep S Jhund, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2018
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial
Daniel E Weiner, Meyeon Park, Hocine Tighiouart, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Circulation
|
January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
Circulation
|
November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Marc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
Page
of 76
Search research articles
Search
Showing results (701-710 of 754) with videos related to
Sort By:
Page
of 76
Clinical Trials (London, England)
|
April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challenges
Thomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal
|
May 3, 2005
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease
T-Christian H Mix, Robert M Brenner, Mark E Cooper, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 28, 2020
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices
Matthew A Sparks, Andrew M South, Andrew D Badley, et al.
Journal of the American College of Cardiology
|
February 28, 2024
Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI
Douglas L Mann, Johny Nicolas, Brian Claggett, et al.
Journal of the American Heart Association
|
November 19, 2021
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON-HF
Leanne Mooney, Nathaniel M Hawkins, Pardeep S Jhund, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 25, 2018
Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial
Daniel E Weiner, Meyeon Park, Hocine Tighiouart, et al.
Circulation. Heart Failure
|
December 10, 2019
Sex-Related Differences in Heart Failure With Preserved Ejection Fraction
Pooja Dewan, Rasmus Rørth, Valeria Raparelli, et al.
Circulation
|
January 30, 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, et al.
Circulation
|
November 20, 2014
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial
Marc A Pfeffer, Brian Claggett, Susan F Assmann, et al.
European Journal of Heart Failure
|
February 20, 2021
Serum potassium and outcomes in heart failure with preserved ejection fraction: a post-hoc analysis of the PARAGON-HF trial
João Pedro Ferreira, Brian L Claggett, Jiankang Liu, et al.
Page
of 76